Other

Deferred compensation plan assets

DexCom Deferred compensation plan assets increased by 0.5% to $20.10M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 9.2%, from $18.40M to $20.10M. Over 3 years (FY 2022 to FY 2025), Deferred compensation plan assets shows an upward trend with a 25.2% CAGR.

Analysis

StatementBalance Sheet Statement
SectionOther
First reportedQ4 2022
Last reportedQ1 2026
Metric ID: other_deferred_compensation_plan_assets_current

Historical Data

13 periods
 Q4 '22Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$10.20M$14.40M$13.70M$15.20M$18.30M$18.30M$19.20M$18.60M$18.40M$19.70M$20.50M$20.00M$20.10M
QoQ Change—+41.2%-4.9%+10.9%+20.4%+0.0%+4.9%-3.1%-1.1%+7.1%+4.1%-2.4%+0.5%
YoY Change———+49.0%—+27.1%+40.1%+22.4%+0.5%+7.7%+6.8%+7.5%+9.2%
Range$10.20M – $20.50M
CAGR+25.4%
Avg YoY Growth+18.9%
Median YoY Growth+9.2%

Frequently Asked Questions

What is DexCom's deferred compensation plan assets?
DexCom (DXCM) reported deferred compensation plan assets of $20.10M in Q1 2026.
How has DexCom's deferred compensation plan assets changed year-over-year?
DexCom's deferred compensation plan assets increased by 9.2% year-over-year, from $18.40M to $20.10M.
What is the long-term trend for DexCom's deferred compensation plan assets?
Over 3 years (2022 to 2025), DexCom's deferred compensation plan assets has grown at a 25.2% compound annual growth rate (CAGR), from $10.20M to $20.00M.